Geoffrey Porges
Stock Analyst at SVB Leerink
(0)
# 2283
Out of 5,252 analysts
172
Total ratings
48.78%
Success rate
634.94%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Pfizer | Maintains: Market Perform | 52 56 | 26.09 | 114.64% | 10 | Dec 15, 2021 | |
Radius Health | Maintains: Market Perform | 30 20 | 12.52 | 59.74% | 10 | Dec 9, 2021 | |
Arcus Biosciences | Maintains: Outperform | 68 100 | 13.19 | 658.15% | 8 | Nov 18, 2021 | |
Regeneron Pharmaceut... | Maintains: Outperform | 798 850 | 675.65 | 25.8% | 15 | Nov 5, 2021 | |
Halozyme Therapeutic... | Maintains: Outperform | 50 48 | 55.79 | -13.96% | 2 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 234 216 | 275.48 | -21.59% | 12 | Nov 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 142 135 | 170.07 | -20.62% | 16 | Nov 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 11 | 11.18 | -1.61% | 1 | Nov 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 75 | 93.08 | -19.42% | 13 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 148 180 | n/a | n/a | 6 | Sep 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Sep 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 29 10 | 10.5 | -4.76% | 9 | Sep 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 30 | 0.5 | 5900% | 8 | Aug 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 342 684 | 0.29 | 235762.07% | 7 | Aug 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 170 175 | 439.92 | -60.22% | 9 | Jul 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Jun 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 96 84 | 14.63 | 474.16% | 3 | May 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Mar 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 196 156 | n/a | n/a | 10 | Mar 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 60 | n/a | n/a | 2 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 33 | 4.88 | 576.23% | 1 | Nov 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 112 100 | n/a | n/a | 3 | Aug 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 7 | Jan 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 61 | 12.02 | 407.49% | 2 | Nov 28, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 32 31 | n/a | n/a | 3 | Sep 4, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 150 160 | n/a | n/a | 3 | Jul 28, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 7 | Mar 16, 2017 |